PCC Rokita SA

WSE:PCR Rapporto sulle azioni

Cap. di mercato: zł1.4b

PCC Rokita Gestione

Gestione criteri di controllo 3/4

PCC Rokita Il CEO è Wieslaw Klimkowski, nominato in Jan2005, e ha un mandato di 19.83 anni. la retribuzione annua totale è PLN 20.28M, composta da 14.1% di stipendio e 85.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.5% delle azioni della società, per un valore di PLN 7.18M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 14.8 anni e 8.8 anni.

Informazioni chiave

Wieslaw Klimkowski

Amministratore delegato

zł20.3m

Compenso totale

Percentuale dello stipendio del CEO14.1%
Mandato del CEO19.8yrs
Proprietà del CEO0.5%
Durata media del management14.8yrs
Durata media del Consiglio di amministrazione8.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?

May 30
Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Aug 24
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 29
PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Is PCC Rokita (WSE:PCR) A Risky Investment?

Jan 18
Is PCC Rokita (WSE:PCR) A Risky Investment?

PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Apr 16
PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Why We Like The Returns At PCC Rokita (WSE:PCR)

Mar 19
Why We Like The Returns At PCC Rokita (WSE:PCR)

What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

Jan 25
What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Sep 01
We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Jun 14
Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

May 18
Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Apr 13
Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

Mar 23
Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Mar 09
PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

Feb 19
Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Feb 04
What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Jan 15
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Dec 30
Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

Dec 17
Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 03
PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Nov 20
Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Wieslaw Klimkowski rispetto agli utili di PCC Rokita?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

zł121m

Jun 30 2024n/an/a

zł158m

Mar 31 2024n/an/a

zł144m

Dec 31 2023zł20mzł3m

zł268m

Sep 30 2023n/an/a

zł473m

Jun 30 2023n/an/a

zł589m

Mar 31 2023n/an/a

zł692m

Dec 31 2022zł43mzł2m

zł675m

Sep 30 2022n/an/a

zł569m

Jun 30 2022n/an/a

zł499m

Mar 31 2022n/an/a

zł472m

Dec 31 2021zł10mzł826k

zł417m

Sep 30 2021n/an/a

zł294m

Jun 30 2021n/an/a

zł247m

Mar 31 2021n/an/a

zł171m

Dec 31 2020zł5mzł573k

zł117m

Sep 30 2020n/an/a

zł73m

Jun 30 2020n/an/a

zł82m

Mar 31 2020n/an/a

zł72m

Dec 31 2019zł4mzł563k

zł93m

Sep 30 2019n/an/a

zł145m

Jun 30 2019n/an/a

zł160m

Mar 31 2019n/an/a

zł201m

Dec 31 2018zł4mzł838k

zł227m

Sep 30 2018n/an/a

zł243m

Jun 30 2018n/an/a

zł215m

Mar 31 2018n/an/a

zł213m

Dec 31 2017zł2mzł314k

zł182m

Compensazione vs Mercato: La retribuzione totale di Wieslaw ($USD 4.89M ) è superiore alla media delle aziende di dimensioni simili nel mercato Polish ($USD 681.72K ).

Compensazione vs guadagni: La retribuzione di Wieslaw è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Wieslaw Klimkowski

19.8yrs

Mandato

zł20,278,000

Compensazione

Mr. Wieslaw Klimkowski serves as the President of the Management Boards at Rokita S.A. and Silesia-Kalk Sp. z o.o. Mr. Klimkowski served as Director of Investor Supervision & Group Development of PCC Rokit...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Wieslaw Klimkowski
President of the Management & General Director19.8yrszł20.28m0.50%
PLN 7.2m
Rafal Zdon
Vice President of the Management Board & Financial Director14.8yrszł16.59m0.34%
PLN 4.8m
Robert Pabich
Secretary of the Supervisory Board & Independent Member of Supervisory Board10yrszł207.00kNessun dato
Beata Dobecka
Chief Accountantno dataNessun datoNessun dato

14.8yrs

Durata media

Gestione esperta: Il team dirigenziale di PCR è esperto e expertise (durata media dell'incarico 14.8 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Robert Pabich
Secretary of the Supervisory Board & Independent Member of Supervisory Board8.7yrszł207.00kNessun dato
Alfred Pelzer
Chairman of the Supervisory Board12.5yrsNessun datoNessun dato
Waldemar Preussner
Deputy Chairman of Supervisory Board12.5yrsNessun datoNessun dato
Mariusz Dopierala
Member of Supervisory Board8.8yrszł204.00kNessun dato
Arkadiusz Szymanek
Independent Member of Supervisory Board7.8yrszł307.00kNessun dato

8.8yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PCR sono considerati esperti (durata media dell'incarico 8.8 anni).